Lanean...
Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin
A review of the literature finds that women diagnosed with breast cancer, who were on an aspirin regimen, experienced a decreased risk of distant metastases and death. Several recent studies have reported an improvement in overall survival in colorectal cancer patients who harbored mutations in the...
Gorde:
| Argitaratua izan da: | Breast Cancer Res Treat |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer US
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4788696/ https://ncbi.nlm.nih.gov/pubmed/26915040 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-3729-8 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|